MedPath

浙江震元制药有限公司

Ownership
-
Established
1997-11-19
Employees
-
Market Cap
-
Website
http://www.zypharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

59

NMPA:59

Drug Approvals

Netilmicin Sulfate

Product Name
硫酸奈替米星
Approval Number
国药准字H10960129
Approval Date
Jun 11, 2024
NMPA

Roxithromycin

Product Name
罗红霉素
Approval Number
国药准字H10950176
Approval Date
Jun 11, 2024
NMPA

Nysfungin

Product Name
制霉素
Approval Number
国药准字H33021392
Approval Date
Jun 11, 2024
NMPA

Cefetamet Pivoxil Hydrochloride

Product Name
盐酸头孢他美酯
Approval Number
国药准字H20010267
Approval Date
Jun 11, 2024
NMPA

Sisomicin Sulfate

Product Name
硫酸西索米星
Approval Number
国药准字H10940143
Approval Date
Jun 11, 2024
NMPA

Clarithromycin

Product Name
克拉霉素
Approval Number
国药准字H20044887
Approval Date
Jun 11, 2024
NMPA

Azithromycin

Product Name
阿奇霉素
Approval Number
国药准字H20043684
Approval Date
Jun 11, 2024
NMPA

Ademetionine 1,4-Butanedisulfonate for Injection

Product Name
注射用丁二磺酸腺苷蛋氨酸
Approval Number
国药准字H20143203
Approval Date
Mar 8, 2024
NMPA

Ademetionine 1,4-Butanedisulfonate

Product Name
丁二磺酸腺苷蛋氨酸
Approval Number
国药准字H20140078
Approval Date
Feb 1, 2024
NMPA

Tropisetron Hydrochloride Capsules

Product Name
盐酸托烷司琼胶囊
Approval Number
国药准字H20080749
Approval Date
Oct 22, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.